Anything Scientific; Oncotarget In It

In so far as traditional scientific journals are concerned Oncotarget has quite a stellar reputation. Its uniqueness lies in its being multi-disciplinary as well as free-access. That apart, they publish papers online on a weekly basis. Moreover, every paper or issue can be printed against a special request.

The raison d’etre behind Oncotarget’s publishing is the furthering of its core mission of reaching scientific results far and wide by making them readily available. It is the publishers’ belief that the impact or research is manifold if embellished with the meaningful review. The more stellar the discovery, the sooner the information needs to reach out. It is the publication’s belief that the different specialties of science need to be in synergy and not at cross purposes.

The myriad fields of bio medical science need to function as parts of a single whole. Oncotarget endeavors to encourage the application of basic as well as clinical science toward the combating of disease. The fact that leading scientists are at the helm of affairs in taking out this journal ensures that all the involved researchers further the cause of science. The most important objective behind the creation of this journal really is the total elimination of disease. Check the journal at SCImago Journal & Country Rank.

In this regards, Oncotarget is known to focus attention on the pathological origin of every type of cancer as well as on finding potential therapy targets. It also weighs in on the treatment protocols put into place to better manage cancer patients with special emphasis on quality of life and adherence to the line of treatment. The journal also compares the results of old and new therapies in terms of achieving better outcomes.

Learn more: https://scholar.google.com/citations?user=REO9YogAAAAJ&hl=en

The journal has achieved outstanding standards of excellence under the stewardship of its editors in chief, Mikhail Blagosklonny, and Andrei V. Gudkov. The fact of the matter is that all manner of cancers need to be studied in depth for effective remedies to be found and there are top- rate researchers engaged in this all the time. By providing them with a well read and networked platform to share their findings Oncotarget is rendering great service to the cause of finding lasting and effective solutions for the most dreaded of diseases. Learn more at researchgate.net about Oncotarget.

Erick Lefkofsky: Battling Cancer with Technology

Erick Lefkofsky: Battling to Cure Cancer

Erick Lefkofsky has done many great things throughout his life, and is definitely trying to leave his footprint on the world. This man has achieved many things in a short amount of time. He has been an inspiration to all those around him and has changed many lives. EricĀ  Lefkofsky was born in Detroit Michigan in 1969 not only is he the founder of groupon, but he is also the founder and CEO of Tempus. Lefkofsky has dedicated his life to his works and helping others.

Tempus is a company that focuses on technology that has a built in operating system that helps to battle cancer. The system uses computer data that is based on genes. This data is used to help get more information while in a clinical setting. The data can help to improve the quality of patients lives. As technology advances there will be more data to learn about, which will hopefully eventually help lead to a cure for cancer and learn more about Eric.

Article Recap

The article starts off by explaining how Tempus plans to use the data system in order to start helping breast cancer patients have a better chance at receiving the best treatment that is currently available to them. Apparently as of right now there is not a lot of data out there about breast cancer patients and treatments, so a lot of times doctors going in doing treatment by trial and error. Hopefully by using data the success rates will increase. This data will show how well patients will respond to each treatment. Tempus was founded in 2015 and has been the biggest new medical sensation since then. The plan is to start moving around and using the data in other centers which will save one life at a time. With advancements in treatment like this this horrible monster will be beat, and lives will be saved with the hard work of others.

Other Reference: https://twitter.com/lefkofsky